• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用于角膜炎-角膜胶原交联(PACK-CXL)的光活化发色团可改善难治性感染性角膜炎的治疗效果。

Photoactivated Chromophore for Keratitis-Corneal Collagen Cross-Linking (PACK-CXL) Improves Outcomes of Treatment-Resistant Infectious Keratitis.

作者信息

Gulias-Cañizo Rosario, Benatti Andres, De Wit-Carter Guillermo, Hernández-Quintela Everardo, Sánchez-Huerta Valeria

机构信息

Universidad Anahuac Mexico, Huixquilucan, Estado de Mexico, Mexico.

Cordoba Eye Clinic, Cornea and Refractive Surgery Department, Cordoba, Argentina.

出版信息

Clin Ophthalmol. 2020 Dec 21;14:4451-4457. doi: 10.2147/OPTH.S284306. eCollection 2020.

DOI:10.2147/OPTH.S284306
PMID:33376299
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7762451/
Abstract

PURPOSE

To investigate the efficacy of photoactivated chromophore corneal collagen cross-linking (PACK)-CXL in the management of treatment-resistant infectious keratitis.

DESIGN

Observational cohort study.

PARTICIPANTS

Forty-two eyes from 41 patients with treatment-resistant infectious keratitis.

METHODS

Eyes underwent PACK-CXL treatment with the Dresden modified protocol in addition to standard antimicrobial therapy. The primary endpoint was the size of the corneal ulcer. Descriptive statistics, Wilcoxon rank test, McNemar test and Spearman correlation coefficient were used for statistical analysis, and values lower than 0.05 were considered statistically significant.

RESULTS

Success rate at third postoperative month was of 90.5%. Statistical analyses showed a significant effect of (PACK)‑CXL with standard antimicrobial therapy to reduce corneal ulcer size (p=0.031).

CONCLUSION

As adjuvant therapy to standard antimicrobial treatment, PACK-CXL improves the outcomes in patients with treatment-resistant corneal ulcers.

摘要

目的

探讨光活化发色团角膜胶原交联术(PACK)-CXL治疗难治性感染性角膜炎的疗效。

设计

观察性队列研究。

参与者

41例难治性感染性角膜炎患者的42只眼。

方法

除标准抗菌治疗外,采用德累斯顿改良方案对眼睛进行PACK-CXL治疗。主要终点是角膜溃疡的大小。采用描述性统计、Wilcoxon秩和检验、McNemar检验和Spearman相关系数进行统计分析,P值低于0.05被认为具有统计学意义。

结果

术后第三个月的成功率为90.5%。统计分析表明,(PACK)-CXL联合标准抗菌治疗对减小角膜溃疡大小有显著效果(P=0.031)。

结论

作为标准抗菌治疗的辅助疗法,PACK-CXL可改善难治性角膜溃疡患者的治疗效果。

相似文献

1
Photoactivated Chromophore for Keratitis-Corneal Collagen Cross-Linking (PACK-CXL) Improves Outcomes of Treatment-Resistant Infectious Keratitis.用于角膜炎-角膜胶原交联(PACK-CXL)的光活化发色团可改善难治性感染性角膜炎的治疗效果。
Clin Ophthalmol. 2020 Dec 21;14:4451-4457. doi: 10.2147/OPTH.S284306. eCollection 2020.
2
Collagen cross-linking with photoactivated riboflavin (PACK-CXL) for the treatment of advanced infectious keratitis with corneal melting.光活化核黄素交联(PACK-CXL)治疗伴有角膜融解的进展性感染性角膜炎。
Ophthalmology. 2014 Jul;121(7):1377-82. doi: 10.1016/j.ophtha.2014.01.011. Epub 2014 Feb 25.
3
Photoactivated chromophore for infectious keratitis - Corneal cross-linking (PACK-CXL): A systematic review and meta-analysis.光激活染色剂在感染性角膜炎中的应用-角膜交联术(PACK-CXL):系统评价和荟萃分析。
Ocul Surf. 2019 Oct;17(4):624-634. doi: 10.1016/j.jtos.2019.08.006. Epub 2019 Aug 8.
4
Evaluation of risk factors for treatment failure in canine patients undergoing photoactivated chromophore for keratitis - corneal cross-linking (PACK-CXL): a retrospective study using additive bayesian network analysis.犬用光激活染色剂治疗角膜炎-角膜交联术(PACK-CXL)失败风险因素的评估:使用加性贝叶斯网络分析的回顾性研究。
BMC Vet Res. 2023 Nov 2;19(1):227. doi: 10.1186/s12917-023-03779-x.
5
Repeated sessions of PACK-CXL WA for the treatment of resistant bacterial keratitis: a retrospective study.重复使用 PACK-CXL WA 治疗耐药性细菌性角膜炎:一项回顾性研究。
BMC Ophthalmol. 2023 Jul 26;23(1):333. doi: 10.1186/s12886-023-03080-3.
6
Evaluation of photoactivated chromophore for keratitis-corneal cross-linking (PACK-CXL) in feline infectious keratitis-patient demographics, treatment protocols, risk factors, and treatment outcome: a retrospective study.猫传染性角膜炎患者人口统计学、治疗方案、危险因素及治疗结果中用于角膜炎-角膜交联(PACK-CXL)的光活化发色团评估:一项回顾性研究
Vet Ophthalmol. 2025 Mar;28(2):330-340. doi: 10.1111/vop.13228. Epub 2024 May 5.
7
Accelerated high fluence photoactivated chromophore for infectious keratitis-corneal cross-linking (PACK-CXL) at the slit lamp: a pilot study.裂隙灯下用于感染性角膜炎-角膜交联(PACK-CXL)的加速高能量光活化发色团:一项初步研究。
Front Pharmacol. 2023 Sep 7;14:1229095. doi: 10.3389/fphar.2023.1229095. eCollection 2023.
8
Corneal Collagen Cross-Linking With Photoactivated Chromophore for Infectious Keratitis After Penetrating Keratoplasty.经穿透性角膜移植术后感染性角膜炎的光激活色原体角膜胶原交联。
Cornea. 2020 Mar;39(3):283-289. doi: 10.1097/ICO.0000000000002210.
9
PACK-CXL vs. antimicrobial therapy for bacterial, fungal, and mixed infectious keratitis: a prospective randomized phase 3 trial.光化学角膜交联联合包装治疗与抗菌治疗对细菌性、真菌性和混合性感染性角膜炎的疗效比较:一项前瞻性随机3期试验
Eye Vis (Lond). 2022 Jan 7;9(1):2. doi: 10.1186/s40662-021-00272-0.
10
Combined Photoactivated Chromophore for Infectious Keratitis-Corneal Collagen Cross-Linking (PACK-CXL) and Therapeutic Penetrating Keratoplasty for Resistant Bacterial Keratitis.用于感染性角膜炎的联合光活化发色团-角膜胶原交联术(PACK-CXL)及治疗性穿透性角膜移植术治疗耐药细菌性角膜炎
Clin Ophthalmol. 2022 Feb 3;16:273-279. doi: 10.2147/OPTH.S348835. eCollection 2022.

引用本文的文献

1
Accelerated high fluence photoactivated chromophore for infectious keratitis-corneal cross-linking (PACK-CXL) at the slit lamp: a pilot study.裂隙灯下用于感染性角膜炎-角膜交联(PACK-CXL)的加速高能量光活化发色团:一项初步研究。
Front Pharmacol. 2023 Sep 7;14:1229095. doi: 10.3389/fphar.2023.1229095. eCollection 2023.
2
Repeated sessions of PACK-CXL WA for the treatment of resistant bacterial keratitis: a retrospective study.重复使用 PACK-CXL WA 治疗耐药性细菌性角膜炎:一项回顾性研究。
BMC Ophthalmol. 2023 Jul 26;23(1):333. doi: 10.1186/s12886-023-03080-3.
3
The Challenges and Therapeutic Prospects in Eye Disease.眼部疾病的挑战与治疗前景
J Pers Med. 2023 May 31;13(6):930. doi: 10.3390/jpm13060930.
4
Keratitis-Review of Current Treatment Possibilities.角膜炎——当前治疗方法综述
J Clin Med. 2021 Nov 23;10(23):5468. doi: 10.3390/jcm10235468.

本文引用的文献

1
Cross-Linking-Assisted Infection Reduction: A Randomized Clinical Trial Evaluating the Effect of Adjuvant Cross-Linking on Outcomes in Fungal Keratitis.交联辅助感染减少:一项评估辅助交联对真菌性角膜炎结局影响的随机临床试验。
Ophthalmology. 2020 Feb;127(2):159-166. doi: 10.1016/j.ophtha.2019.08.029. Epub 2019 Sep 4.
2
Photoactivated chromophore for infectious keratitis - Corneal cross-linking (PACK-CXL): A systematic review and meta-analysis.光激活染色剂在感染性角膜炎中的应用-角膜交联术(PACK-CXL):系统评价和荟萃分析。
Ocul Surf. 2019 Oct;17(4):624-634. doi: 10.1016/j.jtos.2019.08.006. Epub 2019 Aug 8.
3
PACK-CXL: Corneal cross-linking in infectious keratitis.PACK-CXL:感染性角膜炎中的角膜交联。
Eye Vis (Lond). 2016 Apr 19;3:11. doi: 10.1186/s40662-016-0042-x. eCollection 2016.
4
Corneal Collagen Cross-Linking for Infectious Keratitis: A Systematic Review and Meta-Analysis.用于感染性角膜炎的角膜胶原交联:系统评价与荟萃分析。
Cornea. 2016 Jan;35(1):62-71. doi: 10.1097/ICO.0000000000000644.
5
PACK-CXL: Corneal Cross-linking for Treatment of Infectious Keratitis.PACK-CXL:用于治疗感染性角膜炎的角膜交联术
J Ophthalmic Vis Res. 2015 Jan-Mar;10(1):77-80. doi: 10.4103/2008-322X.156122.
6
Corneal cross-linking.角膜交联术
Surv Ophthalmol. 2015 Nov-Dec;60(6):509-23. doi: 10.1016/j.survophthal.2015.04.002. Epub 2015 May 14.
7
Corneal Cross-linking as an Adjuvant Therapy in the Management of Recalcitrant Deep Stromal Fungal Keratitis: A Randomized Trial.角膜交联术作为顽固性深层基质真菌性角膜炎治疗的辅助疗法:一项随机试验
Am J Ophthalmol. 2015 Jul;160(1):131-4.e5. doi: 10.1016/j.ajo.2015.03.024. Epub 2015 Apr 1.
8
Ultraviolet A/riboflavin collagen cross-linking for treatment of moderate bacterial corneal ulcers.紫外线A/核黄素胶原交联术治疗中度细菌性角膜溃疡
Cornea. 2015 Apr;34(4):402-6. doi: 10.1097/ICO.0000000000000375.
9
Evaluation of corneal collagen cross-linking as an additional therapy in mycotic keratitis.评估角膜胶原交联作为真菌性角膜炎的一种辅助治疗方法。
Clin Exp Ophthalmol. 2015 Mar;43(2):103-7. doi: 10.1111/ceo.12399. Epub 2014 Sep 27.
10
Collagen cross-linking with photoactivated riboflavin (PACK-CXL) for the treatment of advanced infectious keratitis with corneal melting.光活化核黄素交联(PACK-CXL)治疗伴有角膜融解的进展性感染性角膜炎。
Ophthalmology. 2014 Jul;121(7):1377-82. doi: 10.1016/j.ophtha.2014.01.011. Epub 2014 Feb 25.